Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (2): 196-197.DOI: 10.3969/j.issn.1673-8640.2022.02.021
Previous Articles Next Articles
Received:2021-02-03
Revised:2021-10-12
Online:2022-02-28
Published:2022-03-15
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.02.021
| 组别 | 例数 | IL-10/(pg/mL) | INF-γ/(ng/L) | sIL-2R/(U/mL) |
|---|---|---|---|---|
| 天疱疮组 | 132 | 93.28±5.41* | 14.59±2.41* | 632.59±43.35* |
| 正常对照组 | 91 | 45.61±3.58 | 57.33±4.12 | 234.68±23.28 |
| 组别 | 例数 | IL-10/(pg/mL) | INF-γ/(ng/L) | sIL-2R/(U/mL) |
|---|---|---|---|---|
| 天疱疮组 | 132 | 93.28±5.41* | 14.59±2.41* | 632.59±43.35* |
| 正常对照组 | 91 | 45.61±3.58 | 57.33±4.12 | 234.68±23.28 |
| 组别 | 例数 | IL-10/(pg/mL) | INF-γ/(ng/L) | sIL-2R/(U/mL) |
|---|---|---|---|---|
| 急性期组 | ||||
| 治疗前 | 71 | 78.16±5.62* | 14.21±2.16* | 674.38±46.21* |
| 治疗4周后 | 71 | 43.23±3.15*# | 42.68±5.63*# | 346.74±32.68*# |
| 缓解期组 | 61 | 83.68±5.89 | 53.12±5.67 | 264.38±28.61 |
| 组别 | 例数 | IL-10/(pg/mL) | INF-γ/(ng/L) | sIL-2R/(U/mL) |
|---|---|---|---|---|
| 急性期组 | ||||
| 治疗前 | 71 | 78.16±5.62* | 14.21±2.16* | 674.38±46.21* |
| 治疗4周后 | 71 | 43.23±3.15*# | 42.68±5.63*# | 346.74±32.68*# |
| 缓解期组 | 61 | 83.68±5.89 | 53.12±5.67 | 264.38±28.61 |
| [1] | 侯丽娟, 李玉华, 王宏伟, 等. 血清IL-33和sST2表达水平与慢性乙型肝炎患者病情相关性研究[J]. 中华医院感染学杂志, 2019, 29(10):1513-1516. |
| [2] | 曲丽梅, 姜元. 布鲁菌病患者血清sTim-3,Galectin-9水平与炎症因子IFN-γ,IL-4水平的相关性[J]. 中华地方病学杂志, 2020, 39(9):654-657. |
| [3] |
OUYANG W, O'GARRA A. IL-10 family cytokines IL-10 and IL-22:from basic science to clinical translation[J]. Immunity, 2019, 50(4):871-891.
DOI URL |
| [4] | 刘爽, 马文成, 张贤英, 等. 过敏性鼻炎患者血清IL-8、IL-22及TNF-α水平的变化及其与病情严重程度的关系研究[J]. 现代生物医学进展, 2020, 20(9):1716-1719. |
| [5] | 李思哲, 闫天萌, 李丽, 等. 血清白细胞介素21水平与大疱性类天疱疮无相关性[J]. 中华皮肤科杂志, 2018, 51(8):595-596. |
| [6] | 周小芳, 宋志强, 邓向芬, 等. 血清抗桥粒芯蛋白1和3抗体在天疱疮临床诊断中的意义[J]. 实用皮肤病学杂志, 2019, 12(2):82-83. |
| [7] |
MUMM J B, EMMERICH J, ZHANG X, et al. IL-10 elicits IFNγ-dependent tumor immune surveillance[J]. Cancer Cell, 2011, 20(6):781-796.
DOI URL |
| [8] |
TAVAKOLPOUR S, MAHMOUDI H, MIRZAZADEH A, et al. Pathogenic and protective roles of cytokines in pemphigus:a systematic review[J]. Cytokine, 2020, 129:155026.
DOI URL |
| [9] | 李志量, 张寒梅, 向睿宇, 等. 抗构象表位桥粒芯蛋白抗体和乙酰胆碱受体抗体滴度与寻常型天疱疮病情活动度的相关性研究[J]. 中华皮肤科杂志, 2020, 53(6):435-438. |
| [10] | RUSSO I, DE SIENA F P, SAPONERI A, et al. Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission[J]. Medicine(Baltimore), 2017, 96(46):e8801. |
| [11] | 李锁, 李志量, 荆可, 等. 桥粒芯糖蛋白抗体与天疱疮临床表型和疾病活动度的关系及其变化规律[J]. 中华皮肤科杂志, 2019, 52(5):297-301. |
| [12] | 曹凯, 陈涛, 付丽新. 寻常型天疱疮22例及大疱性类天疱疮13例白细胞介素-29水平检测分析[J]. 实用皮肤病学杂志, 2020, 13(4):209-211. |
| [1] | DENG Chenxia, MEI Yanping, ZHANG Xia, HUANG Baoshan, TIAN Dan, CAO Mengting, HU Yongqi, LIN Yongping, TIAN Lijun. Depolymerization effect of optical platelet count on reversible platelet aggregation after blood collection [J]. Laboratory Medicine, 2023, 38(11): 1087-1090. |
| [2] | LU Tingyan, GU Danfeng, WANG Yahong, GE Yafang, YANG Haiou. Evaluation of vaginal secretion routine determination modes and review criteria analysis [J]. Laboratory Medicine, 2023, 38(11): 1091-1097. |
| [3] | . [J]. Laboratory Medicine, 2023, 38(11): 1098-1100. |
| [4] | . [J]. Laboratory Medicine, 2023, 38(10): 983-986. |
| [5] | . [J]. Laboratory Medicine, 2023, 38(9): 901-904. |
| [6] | . [J]. Laboratory Medicine, 2023, 38(9): 905-908. |
| [7] | CHENG Xu, YANG Cunqing, PANG Bo, GU Chun, HOU Xueyun, FEI Jiaxin, WU Min, LI Jun, LIU Guijian. Number and activity of peripheral blood eosinophils in obese people [J]. Laboratory Medicine, 2023, 38(9): 855-859. |
| [8] | LEI Jing, MAN Qiuhong, ZHAO Renjia, ZHANG Tiejun, JIANG Yanfeng, XU Kelin, SUO Chen, CHEN Xingdong. Elevated red blood cell distribution width increasing the risk of heart failure:a cohort study based on the UK Biobank [J]. Laboratory Medicine, 2023, 38(9): 860-864. |
| [9] | DUAN Lili, JIANG Chang, ZHOU Dongmei. Role of PLR in ankylosing spondylitis patients with positive antinuclear antibody [J]. Laboratory Medicine, 2023, 38(7): 669-674. |
| [10] | XIA Yanyan, XIA Yongquan, SONG Guanghao, XIA Mao. Role of coagulation-related monitoring indicators in the course of rivaroxaban anticoagulation for acute venous thromboembolism in elderly patients [J]. Laboratory Medicine, 2023, 38(5): 475-478. |
| [11] | CHEN Yi, WANG Jia, XU Zhiwei, ZHAI Yaping, XUAN Weixia. Effects of different anticoagulants on phagocytosis,activation and apoptosis of in vitro neutrophil function [J]. Laboratory Medicine, 2023, 38(5): 479-483. |
| [12] | YANG Liyuan, DAI Wanqin, WANG Xiaotong, LOU Xiaoli, WANG Yue, HOU Yanqiang. Effect of peripheral blood neutrophils on interferon-gamma release assay of Mycobacterium tuberculosis [J]. Laboratory Medicine, 2023, 38(5): 484-488. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(5): 502-504. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(1): 69-72. |
| [15] | XIE Yuan, YI Wanwan, SHI Qiuyuan, LÜ Zhongwei, LIU Jin. Clinical value of thromboelastography and conventional coagulation tests in evaluating coagulation status of colon cancer and colon polyps [J]. Laboratory Medicine, 2022, 37(11): 1007-1011. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||